Compare Prescription Weight Loss Options Side-by-Side
Understanding Which Is Better: Prescription Weight Loss Mechanisms
When evaluating Wegovy or Mounjaro which is better for your weight management goals, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. This prescription-only medicine works by acting on brain appetite centres, potentially reducing food cravings and helping you feel satisfied with reduced portion sizes.
Mounjaro (tirzepatide) takes a dual approach as both a GIP and GLP-1 receptor agonist, targeting two hormone pathways simultaneously. Both treatments require administration alongside a reduced-calorie diet and increased physical activity, representing comprehensive prescription weight loss solutions rather than standalone interventions. Your EverydayMeds prescriber can assess which mechanism may align better with your medical history and weight management objectives.
Pricing Comparison: Which Is Better Value for Prescription Weight Loss
Understanding the cost structure helps determine Wegovy or Mounjaro which is better for your budget planning. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the 2.4mg maintenance dose (£209.99). New customers apply code FIRST40 at checkout, while returning customers use DOSE25 to reach these final prices.
Our bundle options provide convenient multi-month supply planning, such as the Intro Trio (0.25mg, 0.5mg, 1mg) for £299.99 or the Ultimate Stability Trio offering three months of 2.4mg maintenance supply for £649.99. Mounjaro follows a similar escalation structure with comparable pricing points. Both treatments represent significant investments in your health, with prescriber guidance ensuring you select the most appropriate option from the outset.
Clinical Evidence: Which Is Better Supported by Research
The question of Wegovy or Mounjaro which is better from an evidence perspective requires examining their respective clinical trial programmes. Wegovy's efficacy is demonstrated through the STEP trial series, with STEP 1 showing patients achieved approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions (Wilding et al., NEJM, 2021). The recent SELECT cardiovascular outcomes trial also demonstrated a 20% reduction in major cardiovascular events.
Mounjaro's evidence base centres on the SURMOUNT clinical programme, with both treatments showing substantial efficacy in their respective trials. However, direct head-to-head comparisons remain limited due to different trial designs, populations, and endpoints, making it challenging to definitively state which demonstrates superior outcomes across all patient groups.
How Wegovy Works for Prescription Weight Loss Success
Wegovy functions as a GLP-1 receptor agonist, essentially mimicking the action of incretin hormones that your intestines naturally release after eating. When you inject Wegovy once weekly using the FlexTouch pen device, the medication binds to GLP-1 receptors in your brain's appetite control centres, sending signals that promote feelings of fullness and satisfaction. This mechanism may help reduce the psychological drive to eat large portions or seek frequent snacks between meals. The medication also slows gastric emptying, meaning food remains in your stomach longer, contributing to sustained satiety. Unlike appetite suppressants that simply mask hunger, Wegovy works with your body's natural regulatory systems to support healthier eating patterns alongside your prescribed reduced-calorie diet and increased physical activity programme.
Starting Your Prescription Weight Loss Journey
Beginning treatment requires completing EverydayMeds' comprehensive 3-minute online clinical assessment, covering your medical history, current medications, weight management goals, and lifestyle factors. Our qualified prescribers review your assessment within three working days (or 24 hours with express service), determining suitability and recommending the most appropriate treatment option. Once approved, your prescription-only medicine ships via next-day cold-chain delivery, maintaining optimal temperature control throughout transit. The assessment process specifically evaluates whether Wegovy or Mounjaro which is better aligns with your individual circumstances, ensuring personalised treatment selection. All medications are dispensed through our GPhC-registered pharmacy (#9012878), guaranteeing authentic, licensed products direct from manufacturers.
Storage and Practical Considerations
Storage requirements represent a key practical difference when considering Wegovy or Mounjaro which is better for your lifestyle. Wegovy pens must be stored in the refrigerator at 2-8°C before first use but can remain at room temperature (below 30°C) for up to 6 weeks once removed from cold storage. This provides significant flexibility for travel, work schedules, or situations where refrigerated storage isn't immediately available. Mounjaro pens offer only 21 days at room temperature, making Wegovy more convenient for extended trips or variable storage situations. Both medications use simple injection pens requiring weekly administration, with dose escalation following predetermined schedules to minimise potential side effects while optimising therapeutic benefit.
Personalised Treatment Selection for Optimal Results
Determining Wegovy or Mounjaro which is better requires individualised assessment beyond simple efficacy comparisons. Factors including your previous weight loss attempts, concurrent medical conditions, medication interactions, and lifestyle preferences all influence treatment suitability. Some patients may respond preferentially to Wegovy's single-pathway GLP-1 approach, while others might benefit from Mounjaro's dual-receptor mechanism.
Your prescriber considers your complete medical profile, including any history of gastrointestinal conditions, thyroid disorders, or diabetic complications that might favour one treatment over another. Both represent evidence-based prescription weight loss solutions, with the "better" choice ultimately depending on your unique physiological response and practical circumstances rather than universal superiority.
Start Your Prescription Weight Loss Programme Today
Ready to begin your transformation with expert-guided prescription weight loss treatment? Both Wegovy and Mounjaro are immediately available through EverydayMeds, with new customers receiving code FIRST40 and returning customers using DOSE25 at checkout. Our clinical team provides ongoing support throughout your dose escalation and maintenance phases, ensuring optimal results from your chosen treatment pathway. Complete your confidential assessment at https://everydaymeds.co.uk/collections/wegovy to discover which option aligns with your goals. Remember, sustainable weight management represents a long-term commitment, and our GPhC-registered pharmacy (#9012878) provides the professional oversight and authentic medications necessary for safe, effective treatment. Your healthier future starts with the right prescription weight loss solution tailored specifically for you.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
